-
FDA Approves First COVID-19 Vaccine
Today the FDA approved the Pfizer COVID-19 vaccine (now marketed as Comirnaty). Excerpt of the media announcement below: “The FDA’s approval of this vaccine is a milestone as we continue to battle the COVID-19 pandemic. While this and other vaccines have met the FDA’s rigorous, scientific standards for emergency use authorization, as the first FDA-approved…
-
COVID-19 Boosters for The Immunocompromised: University of Iowa Hospitals & Clinics
Information from The University of Iowa Hospitals & Clinics on COVID-19 vaccine boosters for the immunocompromised is here.
-
Advisory Committee on Immunization Practices Meeting on Boosters
There is a meeting of the Advisory Committee on Immunization Practices (ACIP) scheduled for August 30, 2021 to discuss COVID-19 vaccine boosters. It looks like it was originally scheduled for August 24, 2021 but was rescheduled. This link to the Federal Register announcement identifies the matters to be considered (booster doses) of the meeting although…
-
COVID-19 Vaccine Booster Doses May Be available September: Joint Statement from HHS PUblic Health & Medical Experts
The CDC and FDA released a Joint Statement today indicating COVID-19 vaccine booster doses for all Americans possibly beginning as soon as September 2021. An excerpt is below: “We have developed a plan to begin offering these booster shots this fall subject to FDA conducting an independent evaluation and determination of the safety and effectiveness…
-
CDC Publishes Data Prompting the Mask Guideline change
Today the CDC posted the data supporting the change in the mask guidelines for the fully vaccinated. It’s in the July 30, 2021 Morbidity and Mortality Weekly Report (MMWR) describing the outbreak of several hundred new cases of the Delta variant COVID-19 infection in Barnstable County, Massachusetts following July 4th events. Those who were fully…
-
Update on Advisory Committee On Immunization Practices Meeting July 22, 2021
Presentation slides for the ACIP meeting today are available here. Updates to clinical communication indicate that, while patients with a history of Guillain-Barre Syndrome (GBS) are eligible for any of the authorized vaccines, they should discuss with their clinical teams the availability of mRNA vaccines given the association of GBS with the J&J vaccine. For…
-
Advisory Committee On Immunization Practices Meeting July 22, 2021
The Advisory Committee on Immunization Practices (ACIP) will meet with the CDC July 22, 2021 to discuss COVID-19 vaccine boosters for immunocompromised individuals and the association of the J&J vaccine with Guillain-Barre Syndrome. See the draft agenda here.
-
New FDA Warning Regarding association of Guillain-Barre Syndrome with J&J Covid-19 Vaccine
On July 13, 2021, the FDA issued a revision to the J&J COVID-19 vaccine fact sheets regarding the increased risk of Guillain-Barre Syndrome (GBS) with the vaccine. According to the announcement, the benefits still outweigh the risks for getting the vaccine and so far no causal association has been found. GBS is rare and has…
-
Joint CDC and FDA Statement on Vaccine Boosters
See the Joint CDC and FDA statement on vaccine boosters here. Also read the CDC July 2, 2021 COVID Data Tracker Weekly Review here.
-
New Namesake for Johnson County
I never knew until today that Johnson County; Iowa had originally been named for a slaveholder. That has changed since the Johnson County Board of Supervisors voted to rename the county for distinguished African American scholar, Dr. Lulu Merle Johnson on June 24, 2021. Read the Iowa Now story for the details. The drive to…
Go Retire Psychiatrist 